To receive all of Ikonisys’ financial information in real time, send a request by email to [email protected]. Your registration will be immediate.
• The Ikoniscope20 performs immune monitoring functions in a more efficient, simpler and more competitive way than conventional flow cytometers (CMF), the reference tool used for the detection of rare cells
• The Ikoniscope20 detects rare cells with a higher ratio than flow cytometers, also providing detailed cell morphological information with its high quality images
• Monitoring of immune responses in cancer patients is a growing need due to recently approved new immunotherapy treatments
• These results pave the way for new commercialization opportunities for the Ikoniscope20, as a better alternative to the flow cytometer